Erik Steinberg is Director of Allied Medical Governance at GlaxoSmithKline Pharmaceuticals (GSK). He has been leading pharmaceutical research and development activities for multiple companies for the past 30 years. Erik’s expertise is ensuring compliance with worldwide federal regulations in the development of new medications. Presently, he is directing risk management activities making sure all patients are GSK’s number one priority.

Erik graduated from the University of Colorado with his BA in Psychology in 1989 and an MBA in 2003. He has lived in the Denver area since 1976. Currently, Erik lives with his wife, Suzanne, and two sons in Centennial. In his free time, Erik enjoys running, biking, skiing, and traveling. He joined the DFX board in spring 2024.